09/10/2014 - 16:13
MADRID – Results from a phase III trial of a new drug, TAS-102, that mimics the action of fluorouracil showed that it significantly boosted overall survival in heavily pretreated patients with...
Field of Interest: Oncology
Categories:
News Feed: Internal Medicine News - Oncology